Angiosarcoma of the breast.
DOI:
https://doi.org/10.20344/amp.2970Abstract
Angiosarcoma of the breast is a rare but highly malignant neoplasm of vascular origin. The median survival in previously reported cases is 22 months. The treatment of choice is simple mastectomy. Although the value of irradiation or chemotherapy as the only form of treatment is limited, their role as adjuvant therapy should be explored. One case is presented and a review of the literature is made.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
